Literature DB >> 24445912

Landmarks in BPH--from aetiology to medical and surgical management.

Arman Kahokehr1, Peter J Gilling1.   

Abstract

Clinicians treat the symptoms associated with BPH on a daily basis. Although BPH is nearly universal with age, not all men develop lower urinary tract symptoms. Over the past 100 years, several notable advances in the field of urology have not only improved our understanding of the aetiology and natural history of this common disease, but have also facilitated the development of therapeutics to effectively manage BPH-related symptoms. The high quality of modern-day diagnosis, as well as medical and surgical treatment for BPH, is a testimony to centuries of observation and decades of scientific research.

Entities:  

Mesh:

Year:  2014        PMID: 24445912     DOI: 10.1038/nrurol.2013.318

Source DB:  PubMed          Journal:  Nat Rev Urol        ISSN: 1759-4812            Impact factor:   14.432


  58 in total

Review 1.  The standardisation of terminology in lower urinary tract function: report from the standardisation sub-committee of the International Continence Society.

Authors:  Paul Abrams; Linda Cardozo; Magnus Fall; Derek Griffiths; Peter Rosier; Ulf Ulmsten; Philip Van Kerrebroeck; Arne Victor; Alan Wein
Journal:  Urology       Date:  2003-01       Impact factor: 2.649

Review 2.  Objective evaluation of bladder outlet obstruction.

Authors:  P Abrams
Journal:  Br J Urol       Date:  1995-07

3.  Prostaglandins and the prostate: an hypothesis on the etiology of benign prostatic hyperplasia.

Authors:  L A Klein; J S Stoff
Journal:  Prostate       Date:  1983       Impact factor: 4.104

4.  Localized deep microwave hyperthermia in the treatment of poor operative risk patients with benign prostatic hyperplasia.

Authors:  A Yerushalmi; Y Fishelovitz; D Singer; I Reiner; J Arielly; Y Abramovici; R Catsenelson; E Levy; A Shani
Journal:  J Urol       Date:  1985-05       Impact factor: 7.450

5.  KTP laser versus transurethral resection: early results of a randomized trial.

Authors:  David M Bouchier-Hayes; Paul Anderson; Scott Van Appledorn; Pat Bugeja; Anthony J Costello
Journal:  J Endourol       Date:  2006-08       Impact factor: 2.942

6.  Natural history of benign prostatic enlargement: long-term longitudinal population-based study of prostate volume doubling times.

Authors:  Michael M Lieber; Thomas Rhodes; Debra J Jacobson; Michaela E McGree; Cynthia J Girman; Steven J Jacobsen; Jennifer L St Sauver
Journal:  BJU Int       Date:  2009-07-07       Impact factor: 5.588

7.  Altered blood androgens in elderly men with prostate hyperplasia.

Authors:  R Horton; P Hsieh; J Barberia; L Pages; M Cosgrove
Journal:  J Clin Endocrinol Metab       Date:  1975-10       Impact factor: 5.958

8.  Minimally invasive prostatic urethral lift: surgical technique and multinational experience.

Authors:  Thomas A McNicholas; Henry H Woo; Peter T Chin; Damien Bolton; Manuel Fernández Arjona; Karl-Dietrich Sievert; Martin Schoenthaler; Ulrich Wetterauer; Eric J E J Vrijhof; Steven Gange; Francesco Montorsi
Journal:  Eur Urol       Date:  2013-01-19       Impact factor: 20.096

9.  Relief by botulinum toxin of voiding dysfunction due to benign prostatic hyperplasia: results of a randomized, placebo-controlled study.

Authors:  Giorgio Maria; Giuseppe Brisinda; Ignazio Massimo Civello; Anna Rita Bentivoglio; Gabriele Sganga; Alberto Albanese
Journal:  Urology       Date:  2003-08       Impact factor: 2.649

10.  Combination holmium and Nd:YAG laser ablation of the prostate: initial clinical experience.

Authors:  P J Gilling; C B Cass; A R Malcolm; M R Fraundorfer
Journal:  J Endourol       Date:  1995-04       Impact factor: 2.942

View more
  3 in total

Review 1.  Prostatic artery embolization for benign prostatic obstruction: assessment of safety and efficacy.

Authors:  Daniel Christidis; E Clarebrough; V Ly; M Perera; H Woo; N Lawrentschuk; D Bolton
Journal:  World J Urol       Date:  2018-02-14       Impact factor: 4.226

2.  Promotion of epithelial hyperplasia by interleukin-8-CXCR axis in human prostate.

Authors:  Diandra K Smith; Sarrah L Hasanali; Jiaojiao Wang; Georgios Kallifatidis; Daley S Morera; Andre R Jordan; Martha K Terris; Zachary Klaassen; Roni Bollag; Vinata B Lokeshwar; Bal L Lokeshwar
Journal:  Prostate       Date:  2020-06-16       Impact factor: 4.104

Review 3.  Recent advances in the understanding of male lower urinary tract symptoms (LUTS).

Authors:  Arman A Kahokehr; Peter J Gilling
Journal:  F1000Res       Date:  2016-04-21
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.